LiteVax BV
About
LiteVax BV is a biopharmaceutical company focusing on the development and exploitation of novel human vaccine adjuvant products.
Our lead adjuvant candidate outperforms commercially available alternatives with a higher efficacy without overt toxicity.
We are in the clinical stage of development with a second clinical trial focusing on an improved influenza vaccine for the older population.
HEALTH SECTOR
Human health
CLINICAL DEVELOPMENT AND TRIALS
Clinical trials
INVESTMENT AND BUSINESS DEVELOPMENT
Business development and partnerships
THERAPEUTIC AREAS
Infectious diseases
RESEARCH AND DEVELOPMENT
Vaccine adjuvants